🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Study of Three Endpoints to Assess the Benefit of Rehabilitation in Patients With Advanced Non-small Cell Lung Cancer Controlled After at Least 6 Months of Systemic Treatment

Recruitingn/aAges 18 Years - anyAllUniversity Hospital, Grenoble
NCT07434947 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The objective of this study is to identify an outcome that is relevant for assessing the benefit of rehabilitation in patients with advanced or metastatic non-small cell lung cancer whose disease has been stable or responding for at least 6 months with systemic treatment. Many people living with lung cancer experience asthenia, which reduces daily activity, independence, and quality of life. Regular physical activity (PA) is recommended for the management of all chronic diseases, including cancer. PA can be done independently by the patient or supervised by adapted physical activity instructors (EAPA) at home or in a day hospital (HDJ) in medical and rehabilitation care departments (SMR), where it is covered by social security. Rehabilitation program and physical activity may help improve strength, function, and social participation, for patients with non-small cell lung cancer . In

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adult patients treated for NSCLC at CHUGA, CHMS, or CHANGE * Locally advanced or metastatic NSCLC * Tumor disease controlled for at least 6 months following any type of anti-tumor treatment * ECOG Performance Status 0 to 2 * Patient reporting functional complaints related to physical activity * Covered by the national health insurance system Exclusion Criteria: * Initial management of the tumor disease started ≥ 2 years ago * Residual toxicity of grade ≥ 2 * Estimated life expectancy less than 6 months (at the discretion of the investigator) * Patient with an absolute contraindication to physical activity at the time of consultation (e.g., unstable angina; acute intercurrent event...) * Subject currently in an exclusion period from another study or participating in an interventional study
💊

What it tests

  • Not listed
📍

Where

3 sites
Centre Hospitalier Annecy Genevois
Annecy, France
CH Métropole Savoie
Chambéry, France
CHU Grenoble Alpes
Grenoble, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy